UNSPSC 51172435: Benzocaine/bismuth subnitrate/cerium oxalate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA208. This VA Drug Class (GA208) classifies this compound as belonging to the group ANTIDIARRHEAL AGENTS.

UNSPSC 51172435 Benzocaine/bismuth subnitrate/cerium oxalate is a Commodity code with minimal recent state and local procurement activity clearly aligned to its nominal scope. The three recorded opportunities span offender drug testing services (Collin County, Texas), pharmaceutical direct-to-manufacturer procurement (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations explicitly names benzocaine, bismuth subnitrate, or cerium oxalate as line items or required components, and the opportunities appear to be broader pharmaceutical or testing-service procurements tagged to this code without direct relevance to the specific active pharmaceutical ingredients it nominally covers.

Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026, with responses due July 23, 2026, to procure offender specimen collection and drug testing services with an estimated contract value of $600,000 over two years (with three optional one-year renewal periods). The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative purchasing vehicle, posted an RFP due March 26, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed across state and local government facilities in Minnesota and Oregon, with contract effectiveness July 1, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted March 27, 2026, closed April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs. The code shows activity across Texas (county and state levels), Minnesota, and Oregon, but the mismatch between the code's specific ingredient scope and the broad service and product categories being solicited suggests this code may be misapplied in the state and local taxonomy or that these opportunities do not represent the primary procurement category for which benzocaine and related compounds are actually being purchased.